Dr Michael Turner
BA(Hons) BMBCh MRCP(UK) MSc
Michael began his DPhil in October 2020 and is studying the genetic determinants of blood pressure in the Mexico City Prospective Study. The work aims to discover new blood pressure-determining variants and validate the findings made in other populations. He hopes to go on to study the associations of genetically-predicted blood pressure with important causes of death.
Michael has previously completed a BA(Hons) and BMBCh from the University of Oxford before working as a doctor in Manchester and the Thames Valley deanery. He undertook the Oxford MSc in Global Health Science during which he studied the association between UMOD variants and progression of chronic kidney disease. He subsequently went on to Renal and General Medicine specialist training – he has taken time out of this to undertake his DPhil.
Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Ziyatdinov A. et al, (2023), Nature, 622, 784 - 793
MCPS Genetic Cohort Profile code
Software / Code
TORRES J. and TURNER M., (2023)
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology.
Staplin N. et al, (2022), Hypertension
Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study
Ziyatdinov A. et al, (2022)
UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease
Turner M. and Staplin N., (2021), Kidney International, 100, 1168 - 1170